Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cabotegravir”

120 trials

Showing 20 of 120 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05996471
What this trial is testing

Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)

Who this might be right for
HIV Infections
ViiV Healthcare 185
Testing effectiveness (Phase 2)Study completedNCT03639311
What this trial is testing

Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study

Who this might be right for
HIV Infections
ViiV Healthcare 97
Large-scale testing (Phase 3)Looking for participantsNCT07682961
What this trial is testing

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

Who this might be right for
HIV Infections
Gilead Sciences 590
Early research (Phase 1)Study completedNCT02345707
What this trial is testing

Relative Bioavailability Study of Phase III Tablet Formulation of Cabotegravir

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 37
Not applicableStudy completedNCT05152953
What this trial is testing

Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

Who this might be right for
Hiv
University of California, San Francisco 63
Not applicableStudy completedNCT04973254
What this trial is testing

Improving Treatment and Retention Adherence in Nontraditional Settings

Who this might be right for
HIV Infections
Boston Medical Center 25
Not applicableLooking for participantsNCT07221747
What this trial is testing

PathToScale: The PERSIST Trial

Who this might be right for
Oral Pre-exposure Prophylaxis (PrEP)Long-acting Injectable Cabotegravir for PrEP
Georgetown University 9,900
Not applicableNot Yet RecruitingNCT06403865
What this trial is testing

Patient-Reported Outcomes in Real-life of Cabotegravir and Rilpivirine

Who this might be right for
Quality of Life
University Paris 7 - Denis Diderot 280
Early research (Phase 1)Study completedNCT02059031
What this trial is testing

Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 24
Not applicableStudy completedNCT05799339
What this trial is testing

Optimizing CAB-LA as PrEP for Women Who Inject Drugs

Who this might be right for
HIV InfectionsOpioid UseTrauma, Psychological
Alexis Roth 144
Post-approval studies (Phase 4)Study completedNCT05514509
What this trial is testing

A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories

Who this might be right for
HIV Infections
ViiV Healthcare 370
Early research (Phase 1)Study completedNCT03422172
What this trial is testing

A Safety, Tolerability, Acceptability, and Pharmacokinetic (PK) Study of Cabotegravir (CAB) in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Chinese Men

Who this might be right for
HIV Infections
ViiV Healthcare 48
Not applicableLooking for participantsNCT04979728
What this trial is testing

HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots

Who this might be right for
HIV TreatmentHIV Prevention
University of Colorado, Denver 150
Large-scale testing (Phase 3)Active Not RecruitingNCT06134362
What this trial is testing

Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Who this might be right for
HIV Infections
ViiV Healthcare 2,996
Not applicableLooking for participantsNCT07579754
What this trial is testing

BetterInfo on Women's PrEP Choices and Outcomes in Malawi

Who this might be right for
Long-acting Injectable Cabotegravir for PrEPOral Pre-Exposure Prophylaxis (PrEP)
Johns Hopkins Bloomberg School of Public Health 384
Early research (Phase 1)Study completedNCT01848340
What this trial is testing

Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Who this might be right for
HIV-associated Lipodystrophy Syndrome
ViiV Healthcare 16
Post-approval studies (Phase 4)Looking for participantsNCT06646562
What this trial is testing

Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.

Who this might be right for
HIV-1 Infected Adults with Controlled Viremia
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 120
Not applicableActive Not RecruitingNCT06145854
What this trial is testing

Cisgender Female Patients Who Start on Long Acting Cabotegravir for PrEP

Who this might be right for
Hiv
Midway Specialty Care Center 100
Testing effectiveness (Phase 2)Study completedNCT04824131
What this trial is testing

Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Females

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Early research (Phase 1)Study completedNCT02411435
What this trial is testing

Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation